81346 Tyms gene com variants
Also known as: TYMS pharmacogenomic test, 5-FU response prediction
Thymidylate Synthase (TYMS) gene analysis for common variants affecting chemotherapy response and fluorouracil metabolism.
In Plain Language
Chemotherapy response test; Cancer treatment metabolism test
Clinical Context
Identifies TYMS variants predicting response to fluorouracil-based chemotherapy in colorectal and other cancers.
RVU Information
CPT 81346 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81346?
CPT 81346 (Tyms gene com variants) is a Pathology & Lab code. Thymidylate Synthase (TYMS) gene analysis for common variants affecting chemotherapy response and fluorouracil metabolism.
Who uses CPT code 81346?
CPT 81346 is used by Pathology, Pharmacogenomics, Oncology. Identifies TYMS variants predicting response to fluorouracil-based chemotherapy in colorectal and other cancers.
When is CPT 81346 used?
Identifies TYMS variants predicting response to fluorouracil-based chemotherapy in colorectal and other cancers.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.